Menlo Park, CA – According to filings with the U.S. Securities and Exchange Commission, Calysta is raising $120,000,000.00 in a new round of investment. Sources indicate as part of senior management President and Chief Executive Officer, Alan Shaw played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Calysta

Calysta is a biotechnology company leading the world in the development and manufacture of protein ingredients from new sources, which will feed the growing population without causing further damage to our planet. Our first product, FeedKind, is made using very little water and no agricultural land by fermenting natural gas, an abundant source of energy, to create a safe, nutritious, traceable and affordable protein. FeedKind has been commercially validated through extensive customer trials in aquaculture, agriculture and pet food. We are based in Silicon Valley, California and supported by some of the biggest companies in the world.

To learn more about Calysta, visit http://www.calysta.com/

Contact:
Alan Shaw, President and Chief Executive Officer
650-492-6880
ashaw@calysta.com
https://www.linkedin.com/in/alan-shaw-phd-a5117759/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved